FBIO - Fortress Biotech Non-GAAP EPS of -$0.33 misses by $0.18 revenue of $75.7M misses by $23.67M
2023-03-31 00:31:03 ET
- Fortress Biotech press release ( NASDAQ: FBIO ): FY Non-GAAP EPS of -$0.33 misses by $0.18 .
- Revenue of $75.7M (+10.0% Y/Y) misses by $23.67M .
- As of December 31, 2022, Fortress’ consolidated cash, cash equivalents and restricted cash totaled $181.0 million, compared to $210.6 million as of September 30, 2022, and $308.0 million as of December 31, 2021, a decrease of $29.6 million for the fourth quarter and a decrease of $127.0 million for the full year.
For further details see:
Fortress Biotech Non-GAAP EPS of -$0.33 misses by $0.18, revenue of $75.7M misses by $23.67M